DESTINY-Breast06 continues to explore HR⁺, HER2-negative metastatic breast cancer beyond DESTINY-Breast04.

ABSTRACT:

SUBMITTER: Wang F 

PROVIDER: S-EPMC11836743 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature